SCHEMBL21012467

SCHEMBL21012467

O=C(NCc1ccccc1)C(O)CCc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 2/20 0.65
ALDH1A1 P00352 2/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
EPHX1 P07099 1/20 0.53
KMT2A Q03164 1/20 0.51
EPHX2 P34913 1/20 0.50
TSHR P16473 1/20 0.50
MMP1 P03956 1/20 0.50
FCER2 P06734 1/20 0.50
EGFR P00533 1/20 0.49
MME P08473 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.47
GAA P10253 1/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA3 P07451 1/20 0.47
CA4 P22748 1/20 0.47
CA6 P23280 1/20 0.47
CA5A P35218 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26129317 0.85 CYP1A2 (0.63) ALDH1A1SMN1; SMN2KMT2AL3MBTL1
SCHEMBL26129197 0.85 CYP1A2 (0.63) ALDH1A1SMN1; SMN2KMT2AL3MBTL1
SCHEMBL26129199 0.85 CYP1A2 (0.63) ALDH1A1SMN1; SMN2KMT2AL3MBTL1
SCHEMBL20834910 0.85 TSHR (0.53) MMP8ALDH1A1SMN1; SMN2KMT2ATSHR
SCHEMBL16964256 0.85 CYP1A2 (0.53) MMP8KMT2ATSHREGFRMME
SCHEMBL8309569 0.85 TSHR (0.53) MMP8ALDH1A1SMN1; SMN2KMT2ATSHR
SCHEMBL29313120 0.83 GAA (0.62) ALDH1A1KMT2AEPHX2TSHRL3MBTL1
SCHEMBL30562908 0.82 HPGD (0.63) ALDH1A1SMN1; SMN2KMT2ATSHRL3MBTL1
SCHEMBL30567894 0.82 HPGD (0.63) ALDH1A1SMN1; SMN2KMT2ATSHRL3MBTL1
SCHEMBL8411454 0.82 KMT2A (0.54) MMP8ALDH1A1KMT2ATSHREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10294269-B2 Dipeptidyl ketoamide compounds and their use for the treatment and/or prevention of fat accumulation LANDSTEINER GENMED, S.L. (ES) 2019-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10294269-B2 Dipeptidyl ketoamide compounds and their use for the treatment and/or prevention of fat accumulation DPP4, DPP3, DPP8 MMP8 1029/4885ALDH1A1 1198/4885SMN1; SMN2 4472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.